Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.084 | 0.1 |
mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.3 | 0.1 |
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |